Icu Medical [ICUI] vs AptarGroup [ATR] Detailed Stock Comparison

Icu Medical Inc.

NASDAQ
Loading...

AptarGroup, Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Icu Medical Inc. wins in 6 metrics, AptarGroup, Inc. wins in 14 metrics, with 0 ties. AptarGroup, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Icu Medical Inc. AptarGroup, Inc. Better
P/E Ratio (TTM) 4,245.33 21.10 AptarGroup, Inc.
Price-to-Book Ratio 1.48 2.99 Icu Medical Inc.
Debt-to-Equity Ratio 63.48 57.10 AptarGroup, Inc.
PEG Ratio -124.79 -0.84 AptarGroup, Inc.
EV/EBITDA 13.48 11.41 AptarGroup, Inc.
Profit Margin (TTM) 0.03% 10.40% AptarGroup, Inc.
Operating Margin (TTM) 4.82% 11.25% AptarGroup, Inc.
EBITDA Margin (TTM) 4.82% 11.25% AptarGroup, Inc.
Return on Equity 0.04% 15.10% AptarGroup, Inc.
Return on Assets (TTM) 1.66% 6.66% AptarGroup, Inc.
Free Cash Flow (TTM) $82.83M $294.56M AptarGroup, Inc.
Dividend Yield N/A 1.38% N/A
1-Year Return 0.39% -26.86% Icu Medical Inc.
Price-to-Sales Ratio (TTM) 1.43 2.11 Icu Medical Inc.
Enterprise Value $4.18B $9.17B AptarGroup, Inc.
EV/Revenue Ratio 1.87 2.43 Icu Medical Inc.
Gross Profit Margin (TTM) 37.54% 35.13% Icu Medical Inc.
Revenue per Share (TTM) $91 $57 Icu Medical Inc.
Earnings per Share (Diluted) $0.03 $5.88 AptarGroup, Inc.
Beta (Stock Volatility) 0.85 0.49 AptarGroup, Inc.
Short % of Float 6.25% 2.60% AptarGroup, Inc.

Icu Medical Inc. vs AptarGroup, Inc. Stock Performance Analysis

Loading Price Chart...

ICUI
ATR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Icu Medical Inc.0.03%-3.33%9.95%-11.23%-11.03%-5.81%
AptarGroup, Inc.0.31%-3.61%-6.98%-21.37%-7.75%-8.45%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Icu Medical Inc.0.39%-26.60%-34.21%29.31%223.74%231.11%
AptarGroup, Inc.-26.86%1.48%-20.41%50.06%126.49%340.16%

Performance & Financial Health Analysis: Icu Medical Inc. vs AptarGroup, Inc.

MetricICUIATR
Market Information
Market Cap i$3.11B$7.99B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i266,575382,100
90 Day Avg. Volume i286,512472,420
Last Close$130.52$112.53
52 Week Range$107.00 - $160.29$103.23 - $164.28
% from 52W High-18.57%-31.50%
All-Time High$321.70 (Aug 06, 2018)$178.03 (Nov 11, 2024)
% from All-Time High-59.43%-36.79%
Growth Metrics
Quarterly Revenue Growth-0.14%0.14%
Quarterly Earnings Growth-0.14%-0.26%
Financial Health
Profit Margin (TTM) i0.00%0.10%
Operating Margin (TTM) i0.05%0.11%
Return on Equity (TTM) i0.00%0.15%
Debt to Equity (MRQ) i63.4857.10
Cash & Liquidity
Book Value per Share (MRQ)$86.03$41.56
Cash per Share (MRQ)$12.63$6.36
Operating Cash Flow (TTM) i$179.85M$570.00M
Levered Free Cash Flow (TTM) i$394.96M$205.90M
Dividends
Last 12-Month Dividend Yield iN/A1.38%
Last 12-Month Dividend iN/A$1.86

Valuation & Enterprise Metrics Analysis: Icu Medical Inc. vs AptarGroup, Inc.

MetricICUI (Apr 24, 2026)ATR (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i4,245.3321.10
Forward P/E i13.8619.49
PEG Ratio i-124.79-0.84
Price to Sales (TTM) i1.432.11
Price to Book (MRQ) i1.482.99
Market Capitalization
Market Capitalization i$3.11B$7.99B
Enterprise Value i$4.18B$9.17B
Enterprise Value Metrics
Enterprise to Revenue i1.872.43
Enterprise to EBITDA i13.4811.41
Risk & Other Metrics
Beta i0.850.49
Book Value per Share (MRQ) i$86.03$41.56

Financial Statements Comparison: Icu Medical Inc. vs AptarGroup, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricICUI (2025)ATR (2025)
Revenue/Sales i2.23B3.78B
Cost of Goods Sold i1.41B2.37B
COGS % of Revenue i63.2%62.8%
Gross Profit i822.04M1.40B
Gross Margin i36.8%37.2%
Research & Development i87.50MN/A
Operating Income (EBIT) i109.33M510.88M
Operating Margin i4.9%13.5%
EBITDA i320.73M841.80M
EBITDA Margin i14.4%22.3%
Pre-Tax Income i4.36M491.38M
Pre-Tax Income % of Revenue i0.2%13.0%
Income Tax i2.44M98.88M
Income Tax % of Revenue i0.1%2.6%
Net Income (Profit) i732,000392.50M
Profit Margin i0.0%10.4%

Balance Sheet & Liquidity Metrics

MetricICUI (2025)ATR (2025)
Cash & Equivalents i307.96M402.42M
Total Current Assets i1.19B1.89B
Total Current Assets % of Revenue i53.4%50.1%
Total Current Liabilities i498.86M1.17B
Total Current Liabilities % of Revenue i22.4%30.9%
Long-Term Debt i1.31B1.19B
Long-Term Debt % of Revenue i58.9%31.4%
Total Shareholders Equity i2.12B2.71B
Retained Earnings i690.89M2.64B
Retained Earnings % of Revenue i31.0%70.0%
Property, Plant & Equipment i492.78M65.70M

Cash Flow Statement Comparison

MetricICUI (2025)ATR (2025)
Operating Cash Flow i263.01M590.78M
Operating Cash Flow % of Revenue i11.8%15.6%
Capital Expenditures i-88.04M3.55M
Free Cash Flow i82.83M294.56M
FCF Margin i3.7%7.8%
Debt Repayment i-304.80M-194.78M
Common Stock Repurchase iN/A-365.01M

Short Interest & Institutional Ownership Analysis

MetricICUIATR
Shares Short i1.30M1.46M
Short Ratio i4.682.79
Short % of Float i6.25%2.60%
Shares Outstanding i24.69M64.21M
Float Shares i24.21M63.80M
% Held by Insiders i3.79%0.80%
% Held by Institutions i114.71%96.42%
% Held by Public i-18.50%2.78%

Dividend Analysis & Yield Comparison: Icu Medical Inc. vs AptarGroup, Inc.

MetricICUIATR
Last 12-Month Dividend iN/A$1.86
Last 12-Month Dividend Yield iN/A1.38%
3-Year Avg Annual Dividend iN/A$1.74
3-Year Avg Dividend Yield iN/A0.32%
3-Year Total Dividends iN/A$5.23
Ex-Dividend DateN/AFeb 04, 2026